Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?

被引：4
作者：
Kotsopoulos, Joanne [1 ,2 ]
Narod, Steven A. [1 ,2 ]
机构：
[1] Womens Coll Hosp, Womens Coll Res Inst, 76 Grenville St,6th Floor, Toronto, ON M5S 1B2, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2018年 / 18卷 / 03期
关键词：
BRCA; breast cancer; ovarian cancer; prophylactic mastectomy; survival; BREAST-CANCER; HEREDITARY BREAST; RISK; WOMEN;
D O I：
10.1080/14737140.2018.1424547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 11 条
  • [1] Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study
    Cortesi, Laura
    De Matteis, Elisabetta
    Toss, Angela
    Marchi, Isabella
    Medici, Veronica
    Contu, Giannina
    Xholli, Anjeza
    Grandi, Giovanni
    Cagnacci, Angelo
    Federico, Massimo
    [J]. ONCOLOGY, 2017, 93 (06) : 377 - 386
  • [2] Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
    Evans, D. Gareth
    Wisely, Julie
    Clancy, Tara
    Lalloo, Fiona
    Wilson, Mary
    Johnson, Richard
    Duncan, Jonathon
    Barr, Lester
    Gandhi, Ashu
    Howell, Anthony
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [3] Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
    Finch, Amy P. M.
    Lubinski, Jan
    Moller, Pal
    Singer, Christian F.
    Karlan, Beth
    Senter, Leigha
    Rosen, Barry
    Maehle, Lovise
    Ghadirian, Parviz
    Cybulski, Cezary
    Huzarski, Tomasz
    Eisen, Andrea
    Foulkes, William D.
    Kim-Sing, Charmaine
    Ainsworth, Peter
    Tung, Nadine
    Lynch, Henry T.
    Neuhausen, Susan
    Metcalfe, Kelly A.
    Thompson, Islay
    Murphy, Joan
    Sun, Ping
    Narod, Steven A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1547 - U43
  • [4] The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy
    Giannakeas, Vasily
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 263 - 267
  • [5] The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
    Hartmann, Lynn C.
    Lindor, Noralane M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05) : 454 - 468
  • [6] Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status
    Kotsopoulos, Joanne
    Rosen, Barry
    Fan, Isabel
    Moody, Joel
    McLaughlin, John R.
    Risch, Harvey
    May, Taymaa
    Sun, Ping
    Narod, Steven A.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 42 - 47
  • [7] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [8] Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer
    Lee, Jihyoun
    Kim, Sungwon
    Kang, Eunyoung
    Park, Suyeon
    Kim, Zisun
    Lee, Min Hyuk
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (02) : 203 - 207
  • [9] Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    Mcgee, Jacob
    Giannakeas, Vasily
    Karlan, Beth
    Lubinski, Jan
    Gronwald, Jacek
    Rosen, Barry
    McLaughlin, John
    Risch, Harvey
    Sun, Ping
    Foulkes, William D.
    Neuhausen, Susan L.
    Kotsopoulos, Joanne
    Narod, Steven A.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 (02) : 346 - 351
  • [10] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer, H
    van Geel, B
    van Putten, WLJ
    Henzen-Logmans, SC
    Seynaeve, C
    Menke-Pluymers, MBE
    Bartels, CCM
    Verhoog, LC
    van den Ouweland, AMW
    Niermeijer, MF
    Brekelmans, CTM
    Klijn, JGM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 159 - 164
12